ODI
Obesity and Diabetes Innovators
1D:
1M: -2.43%
YTD: +10.71%
3Y: +16.78%
Total Return
Current Companies
See every company in this theme
Create a free account to see the full holdings, why each company is here, and the news moving them.
Create an account to unlockDescription
This theme focuses on companies advancing GLP-1 therapies for obesity and diabetes. It covers organizations specializing in GLP-1 drug research, clinical trials, manufacturing, and cutting-edge drug delivery solutions that enhance treatment outcomes and patient convenience.
Inception 01/01/2021As of 10/09/2026
Latest News
Follow the news moving this theme
Create a free account to read the latest headlines on the companies in this basket.
Create an account to unlock